Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Metoclopramide in hematology].

J Gardais

    La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
    |September 2, 1982
    PubMed
    Summary

    Metoclopramide effectively prevents chemotherapy-induced nausea and vomiting in hematology patients. This medication is well-tolerated, even at high doses, and aids gastric emptying.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is there any significance for intracellular crystals in plasma cells from patients with monoclonal gammopathies?

    European journal of haematology·2001
    Same author

    [Chronic lymphoid hemopathies in adults: chronic lymphocytic leukaemia and the phase of dissemination of small cell lymphomas].

    Annales de biologie clinique·2001
    Same author

    Dyshaemopoiesis in adults: a practical classification for diagnosis and management.

    Leukemia research·2000
    Same author

    Is there still a place for clinical staging in chronic lymphocytic leukaemia?

    Leukemia research·1999
    Same author

    Successive transformation of chronic myelomonocytic leukaemia into acute myeloblastic then lymphoblastic leukaemia, both with minor-bcr rearrangement.

    British journal of haematology·1997
    Same author

    C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.

    The Journal of allergy and clinical immunology·1996

    Area of Science:

    • Pharmacology
    • Hematology
    • Oncology

    Context:

    • Metoclopramide has been used for two decades in France.
    • It is administered intravenously and orally.
    • Used in patients undergoing chemotherapy for leukemia or lymphoma.

    Purpose:

    • To inhibit nausea and vomiting induced by antineoplastic treatments.
    • To prevent digestive discomfort during sequential chemotherapy.
    • To assess tolerance and efficacy of metoclopramide in hematology patients.

    Summary:

    • Intravenous metoclopramide prevents nausea and vomiting during chemotherapy for leukemia and lymphoma.
    • Oral administration extends the antiemetic effect for several hours with no reported side effects.
    • High doses are well-tolerated, even in patients with gastrointestinal issues, due to accelerated gastric evacuation.

    Impact:

    • Metoclopramide improves patient tolerance to chemotherapy.
    • It offers a safe and effective antiemetic solution.
    • The drug's ability to accelerate gastric evacuation benefits patients with gastritic or ulcerous conditions.

    Related Experiment Videos